99485-76-4

Basic information

• Product Name: CUMYLURON
• Synonyms: CUMYLURON;C-940;1-(2-chlorophenyl)-3-(1-methyl-1-phenylethyl)urea;N-(2-chlorophenyl)-N′-(1-methyl-1-phenylehtyl)urea;CUMYLURON STANDARD;Cumyluron [iso];1-(2-Chlorobenzyl)-3-(alpha,alpha-dimethylbenzyl)urea;Dibenzyluron
• CAS NO: 99485-76-4
• Molecular Formula: C12H16N2O2
• Molecular Weight: 220.27
• Mol File: 99485-76-4.mol
• Article Data: 0

Chemical Properties

• Melting Point: 167.9℃165～170℃approximate 173℃
• Boiling Point: 503 °C at 760 mmHg
• Flash Point: 258 °C
• Appearance: /
• Density: 1.164
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.575
• Storage Temp.: 0-6°C
• PKA: 13.33±0.46(Predicted)
• CAS DataBase Reference: CUMYLURON(CAS DataBase Reference)
• NIST Chemistry Reference: CUMYLURON(99485-76-4)
• EPA Substance Registry System: CUMYLURON(99485-76-4)

Safety Data

• Statements: 52/53
• Safety Statements: 61
• Hazardous Substances Data: 99485-76-4(Hazardous Substances Data)

Usage

Description

CUMYLURON, with the molecular formula C18H24N2O2, is a synthetic cannabinoid that functions as a potent agonist for the cannabinoid receptors CB1 and CB2. It is characterized by its high binding affinity for the CB1 receptor and has been extensively studied for its potential pharmacological and therapeutic effects. These effects include modulation of pain, inflammation, and other physiological processes. However, due to its psychoactive and addictive properties, CUMYLURON is a controlled substance that requires careful handling and use under proper supervision.

Uses

Used in Pharmaceutical Industry:
CUMYLURON is used as a pharmacological agent for its potential therapeutic effects on pain and inflammation. Its agonistic action on cannabinoid receptors CB1 and CB2 suggests potential applications in managing chronic pain conditions and inflammatory diseases.
Used in Research Applications:
In the scientific community, CUMYLURON is utilized as a research tool to study the effects and mechanisms of cannabinoid receptor activation. This helps in understanding the role of the endocannabinoid system in various physiological and pathological processes.
Used in Drug Development:
CUMYLURON's high binding affinity and selectivity for the CB1 receptor make it a candidate for drug development, particularly for conditions where modulation of the endocannabinoid system could be beneficial. However, the development and use of CUMYLURON-based drugs must consider its controlled status and associated risks.

InChI:InChI=1/C17H19ClN2O/c1-17(2,14-9-4-3-5-10-14)20-16(21)19-12-13-8-6-7-11-15(13)18/h3-11H,12H2,1-2H3,(H2,19,20,21)